Sara Arcudi/LinkedIn
Jan 3, 2026, 10:32
Sara Arcudi: Anti-emicizumab Antibodies and Their Relevance in Clinical Practice
Sara Arcudi, Consultant Physician at Centro Cardiologico Monzino, shared a post on LinkedIn:
“I am pleased to contribute to the advancement of emicizumab management with our latest clinical insights.”
Anti-emicizumab antibodies and their relevance in clinical practice
Authors: Carla Valsecchi, Lucia Schiavone, Sara Arcudi, Adriana Torri, Cristina Novembrino, Flora Peyvandi
Read more.
Stay Updated with Hemostasis Today.
-
Oct 10, 2026, 16:11David C. Madoff: HCC With Portal Vein Tumor Thrombosis East vs West
-
Oct 10, 2026, 15:50M Velia Antonini: ECMO Cannula Design and Its Impact on Blood Flow, Thrombosis and Hemolysis
-
Oct 10, 2026, 15:14Cihan Ay: PhD With Distinction in Thrombosis Research in Patients With Primary Brain Tumors
-
Oct 10, 2026, 15:07Khalid Ahmed: Mortality and Survival in Young People With Sickle Cell Disease and Beta Thalassaemia in England 1997 to 2025
-
Oct 10, 2026, 14:59Matteo Foschi: Antithrombotic Therapy in Secondary Stroke Prevention 10 Clinical Pearls Every Clinician Should Know
-
Oct 10, 2026, 14:33Ahmad Gharehbaghian: Supporting Blood Transfusion Teams and Strengthening Iran’s Blood Supply
-
Oct 10, 2026, 14:17Caitlin Raymond: Long-Term Infection Risk With ECP in GVHD
-
Oct 10, 2026, 14:09Emmanuel J Favaloro: 100 years of von Willebrand Disease in 2026
-
Oct 10, 2026, 13:54WFH Strengthens Collaboration to Advance Hemophilia Care in Paraguay